Changes between two versions
What changed between the plenary report and the adopted text
From · plenary report· 21 Sept 2023
on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures
To · adopted text· 4 Oct 2023
Classification, labelling and packaging of substances and mixtures
+4 added · −11 removed · 13 changed paragraphs, packaging included.
Part 4 of 4: Paragraphs 181–190
10 unchanged paragraphs
Regulation (EC) No 1272/2008
Annex II – paragraph 1 – point 1, Annex II – Part 3 – Section 3.4 – point b: (b) a label is firmly affixed on a visible place of the refill station and fulfils the requirements of Article 31;
Regulation (EC) No 1272/2008
Annex II – paragraph 1 – point 1, Annex II – Part 3 – Section 3.4 – point b a (new): (ba) a label is available at the refill station, free-of-charge for consumers in a self-adhesive sticker form to be affixed on the container used by the consumer. Where refill stations provide several substances or mixtures, labels should easily and clearly identify which substance or mixture provided at the refill station the labels correspond to;
Regulation (EC) No 1272/2008
Annex II – paragraph 1 – point 1, Annex II – Part 3 – Section 3.4. – point k – point iv a (new): (iva) Serious eye damage category 1/eye irritation, category 2;
Regulation (EC) No 1272/2008
Annex II – paragraph 1 – point 1, Annex II – Part 3 – Section 3.4. – point k – point v a (new): (va) Skin sensitisation, category 1 (sub-categories 1A and 1B);
Regulation (EC) No 1272/2008
Annex III – paragraph 1 a (new), Annex VI: Annex VI is amended as follows: / "ANNEX VI / — Justification for the proposed grouping of substances to harmonized classification and labelling. / Where a harmonised classification and labelling proposal is made for a group of substances, the dossier shall include a scientific justification. / — Justification for other effects at Community level / For effects other than carcinogenity, mutagenicity, reprotoxicity, endocrine disruption for human health and the environment, persistent bioaccumulative and toxic (PBT), very persistent, very bioaccumulative (vPvB), persistent, mobile and toxic (PMT), very persistent, very mobile (vPvM), and respiratory sensitisation, a justification that there is a need for action demonstrated at Union level shall be provided. This will not apply for an active substance within the meaning of Regulation (EU) No 1107/2009 or Regulation (EU) No 528/2012."